These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Does flow-limited portal arterialization avoid the disadvantages of portacaval shunts in healthy and cirrhotic rats? (author's transl)]. Hirner A, Häring R, Karavias T. Chir Forum Exp Klin Forsch; 1980; ():155-9. PubMed ID: 7389447 [Abstract] [Full Text] [Related]
23. Liver arterialization with portacaval shunt in the cirrhotic rat. Lecompte Y, Franco D, Martin ED, Bismuth H. Surgery; 1974 Feb; 75(2):161-8. PubMed ID: 4812043 [No Abstract] [Full Text] [Related]
25. Significance of hemodynamic studies in the evaluation of portal hypertension. Smith GW. Am Surg; 1973 Jan; 39(1):40-7. PubMed ID: 4686134 [No Abstract] [Full Text] [Related]
38. [Indications and technics of portacaval shunt in cirrhosis]. Maillard JN, Flamant Y. Gastroenterol Clin Biol; 1977 Mar 26; 1(8-9):613-9. PubMed ID: 913959 [No Abstract] [Full Text] [Related]
39. [Experimental liver arterialization following portacaval shunt - rehabilitation]. Hirner A, Häring R. Chirurg; 1981 Jun 26; 52(6):389-97. PubMed ID: 7249857 [Abstract] [Full Text] [Related]
40. [New aspects of liver circulation: effects and consequences for the portocaval shunt therapy in liver cirrhosis]. Thiel H. Schweiz Med Wochenschr; 1979 Mar 03; 109(9):297-304. PubMed ID: 373112 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]